Urethral stricture is scarring in the urethra, the tube that moves urine out of your body. The scarring blocks or narrows your urethra and makes it difficult to urinate. It can cause pain. If left ...
Urethral strictures refer to the narrowing of the urethra, which is the tube that carries urine out of the body. This condition is typically caused by scarring, which can block or narrow the urethra, ...
Radiation therapy is an essential treatment for prostate cancers. Complications from radiation are very rare, but occasionally men can develop a urethral stricture after radiation treatment. The ...
Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis. Investigators in South Korea demonstrated the benefit in a ...
A 56-year-old male with complete paraplegia at T-4 underwent visual internal urethrotomy of bulbous urethral stricture with a cold knife at 12 o'clock position. There was brisk arterial bleeding.
A team of surgeons in the University College Hospital (UCH), Ibadan, led by Prof. Olayinka Shittu, has successfully performed an intricate procedure to reconstruct a urethral stricture in a ...
The Optilume device includes a balloon coated with paclitaxel. The Food and Drug Administration (FDA) has approved the Optilume ® Urethral Drug Coated Balloon (DCB) to treat patients with obstructive ...
STRICTURES of the human urethra are of three types: inflammatory, traumatic and congenital. The basic histology 1 common to all strictures is a proliferation of fibroblasts in the tunica propria. This ...
Guidelines for male urethral stricture The guidelines provide a clinical framework for the diagnosis and treatment of male urethral stricture. A clinical framework to guide providers in the diagnosis ...
Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer duration of relief to patients ...
Optilume is a urethral balloon coated with paclitaxel (3.5 microgram/mm 2). It is indicated for managing urethral stricture disease in 'adult males'. It is designed to be used as a drug-coated ...